Black Swan Analysis

Black Swan Analysis

Black Swan Analysis, founded in 2007, is a unique analysis practice that provides robust valuations and commercialisation plans to optimise products in the healthcare industry. We know what it takes to succeed in this industry -we’ve seen what works and what doesn’t and we are committed to bringing insight and high quality solutions to our clients. In doing so we help them meet the many challenges of today’s complex healthcare marketplace.

The Black Swan team has a unique skill set: the ability to develop dynamic market forecasts and interactive patient flow models using a wide range of data including complex pathological and epidemiological information. As pharmaceutical and healthcare companies are challenged to deliver more specific targets that align with unmet medical needs. These modelling approaches are more commercially focused to meet the requirements of a changing healthcare environment.

We have the capability to provide an immediate and ‘hands-on’ approach with every client and where the right internal expertise is leveraged we can help find your optimal solution. Using our bespoke methodologies and frameworks we seek to assess the most challenging valuations.

The valuation outputs we generate can be easily integrated with any in-house existing financial systems, presentation styles or platforms that may be currently operational. This ensures a faster uptake within the business, enabling resources to be re-directed towards implementing the outputs and leveraging new information.

Our philosophy at Black Swan is to create the right environment using inclusive dialogues and collaboration that enable us to generate outputs that make business decisions clear. Our goal is to provide an unparalleled level of satisfaction and quality for our clients.

 
Black Swan Analysis
No of Report:169
  • Epiomic Epidemiology Series: Myasthemia Gravis Forecast in 26 Major Markets 2017-2027

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Myasthenia Gravis in 26 Major Markets Myasthenia Gravis (MG), also known as autoimmune myasthenia, is one of the most significant diseases affecting the neuromuscular junction. The disorder is caused by auto-antibodies that target components of the post-synaptic muscle endplate. This includes antibodies that target acetylcholine receptors (AChR), muscle-specific kinase (MUSK) and lipoprotein ...

    April 2017    |    $5650    |    View Details >>

  • Epiomic Epidemiology Series: Oesophageal Cancer Forecast in 18 Major Markets 2017-2027

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Oesophageal Cancer in 18 Major Markets

    March 2017    |    $5650    |    View Details >>

  • Epiomic Epidemiology Series: Ankylosing Spondylitis Forecast in 13 Major Markets 2017-2027

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Ankylosing Spondylitis in 13 Major Markets

    March 2017    |    $5650    |    View Details >>

  • Epiomic Epidemiology Series: Dyslipidaemia Forecast in 12 Major Markets 2017-2027

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Dyslipidaemia in 12 Major Markets

    March 2017    |    $5650    |    View Details >>

  • Epiomic Epidemiology Series: Type 1 Diabetes Mellitus Forecast in 12 Major Markets 2017-2027

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Type 1 Diabetes Mellitus in 12 Major Markets Type 1 Diabetes Mellitus (T1DM) is a multisystem disease that progressively destroys the pancreas' ability to produce insulin. This leads to a chronic condition of defective metabolism of fat, carbohydrates and proteins due to the lack of insulin. It occurs mainly in childhood and ...

    March 2017    |    $5650    |    View Details >>

  • Epiomic Epidemiology Series: Mucopolysaccharidosis-III (MPS-III) Sanfilippo Syndrome Forecast in 23 Major Markets 2017-2027

    Black Swan Analysis Epiomic� Epidemiology Series Forecast Report on MPS-III (Sanfilippo Syndrome) in 23 Major Markets Mucopolysaccharidosis-III, also known as MPS-III or Sanfilippo syndrome, is part of the Mucopolysaccharidoses (MPS) disorders - a group of rare genetic disorders caused by deficiencies of lysosomal enzymes. These are in-born errors of metabolism, and are autosomal recessive genetic disorders. There are 4 distinct sub-types of ...

    February 2017    |    $5650    |    View Details >>

  • Epiomic Epidemiology Series: Non-Hodgkin Lymphoma Forecast in 18 Major Markets 2017-2027

    Black Swan Analysis Epiomic� Epidemiology Series Forecast Report on Non-Hodgkin Lymphoma in 18 Major Markets Non-Hodgkin Lymphomas (NHL) are a diverse group of blood cancers that develop from lymphocytes (a type of white blood cell). As the name suggests, they include all lymphomas except Hodgkin�s lymphoma. There are about 35 different subtypes of Non-Hodgkin Lymphomas. These are divided into two groups; ...

    February 2017    |    $5650    |    View Details >>

  • Epiomic Epidemiology Series: Bell's Palsy Forecast in 15 Major Markets 2017-2027

    Black Swan Analysis Epiomic� Epidemiology Series Forecast Report on Bell�s palsy in 15 Major Markets Bell's palsy, also known as idiopathic facial nerve palsy, is a weakness of the muscles on one side of the face caused by the compression of the facial/cranial nerve, with no known underlying pathological cause. Such a condition typically manifests in a unilateral paralysis of the ...

    February 2017    |    $5650    |    View Details >>

  • Epiomic Epidemiology Series: Mucopolysaccharidosis-II (MPS-II) Hunter Syndrome Forecast in 26 Major Markets 2017-2027

    Black Swan Analysis Epiomic� Epidemiology Series Forecast Report on MPS-II (Hunter Syndrome) in 26 Major Markets Mucopolysaccharidosis-II, also known as MPS-II or Hunter syndrome, is part of the Mucopolysaccharidoses (MPS) disorders - a group of rare genetic disorders caused by deficiencies of lysosomal enzymes. MPS II is caused by deficiency of the lysosomal enzyme iduronate-2-sulphatase (IDS gene) leading to progressive accumulation ...

    February 2017    |    $5650    |    View Details >>

  • Epiomic Epidemiology Series: Osteopenia & Osteoporosis Forecast in 13 Major Markets 2017-2027

    Black Swan Analysis Epiomic� Epidemiology Series Forecast Report on Osteopenia and Osteoporosis in13 Major Markets Osteopenia and osteoporosis (�porous bone�) are both terms which help to define the continuum of loss of bone density which leads to bone fragility and an increased risk of fractures of the hip, spine and wrist. Loss of bone density is characterised by too little bone ...

    February 2017    |    $5650    |    View Details >>

  • Epiomic Epidemiology Series: Liver Cancer Forecast in 18 Major Markets 2017-2027

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Liver Cancer in 18 Major Markets Liver Cancer, also known as hepatic cancer or primary liver cancer, is a cancer which starts in the cells of the liver. The most common form is hepatocellular carcinoma (HCC) which originates from hepatocytes, the most abundant cell type in the liver, although other cell types ...

    February 2017    |    $3950    |    View Details >>

  • Epiomic Epidemiology Series: Irritable Bowel Syndrome Forecast in 12 Major Markets 2017-2027

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Irritable Bowel Syndrome in 12 Major Markets Irritable Bowel Syndrome (IBS) is a functional bowel disorder which incorporates a group of symptoms but includes abdominal pain and disturbed defecation. IBS is divided into several subtypes including: • Diarrhoea predominant (IBS-D) • Constipation predominant (IBS-C) • Alternating (IBS-A) • Pain predominant. These subtypes are identified by ...

    February 2017    |    $3950    |    View Details >>

  • Epiomic Epidemiology Series: Lewy Body Dementia Forecast in 12 Major Markets 2017-2027

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Lewy Body Dementia in 12 Major Markets Dementia with Lewy Bodies (DLB) is the second most frequent cause of age related neurodegenerative dementia, accounting for approximately a third of all dementias. The presence of Lewy bodies in the brain is linked to low levels of important chemical messengers and the loss of ...

    February 2017    |    $3950    |    View Details >>

  • Epiomic Epidemiology Series: Alzheimer's Disease Forecast in 12 Major Markets 2017-2027

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Alzheimer’s disease in 12 Major Markets Alzheimer's disease (AD) is a progressive, irreversible neurodegenerative disorder. It is the leading cause of dementia. Alzheimer’s is associated with the increase of beta amyloid and tau proteins in the brains of affected patients. Cognitive function declines and patients suffer memory loss and disorientation amongst many ...

    February 2017    |    $3950    |    View Details >>

  • Epiomic Epidemiology Series: Chronic Hepatitis C Forecast in 12 Major Markets 2017-2027

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Chronic Hepatitis C in 12 Major Markets Hepatitis C is a single-stranded RNA virus that infects and damages the liver. In most cases, hepatitis C causes no noticeable symptoms until the liver has been significantly damaged. Symptoms are often vague such as flu-like muscle aches and fatigue. This report provides the current ...

    January 2017    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Muscular Dystrophies Forecast in 12 Major Markets 2017-2027

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Muscular Dystrophies in 12 Major Markets The muscular dystrophies (MD) are a group of more than 30 genetic diseases characterized by progressive muscle weakness and degeneration leading to reduced mobility. The specific types of MD are classified based on severity, pattern of inheritance, age at onset, affected muscle groups or other organs, ...

    January 2017    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Vascular Dementia Forecast in 13 Major Markets 2017-2027

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Vascular Dementia in 13 Major Markets Vascular Dementia (VaD) is the second most common form of dementia after Alzheimer disease. It is also known as multi-infarct dementia (MID) and vascular cognitive impairment (VCI), and is caused by issues with blood supply to the brain, typically caused by a series of minor ...

    January 2017    |    $5850    |    View Details >>

  • Rotavirus Group A Forecast for selected Asian Markets 2017-2027

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Rotavirus Group A for Selected Asian Markets Rotavirus is a contagious virus that can cause gastroenteritis (inflammation of the stomach and intestines). Symptoms include severe watery diarrhoea, often with vomiting, fever, and abdominal pain. Rotavirus infects and damages the cells that line the small intestine, causing gastroenteritis. It is the most frequent ...

    January 2017    |    $2300    |    View Details >>

  • Cholera Forecast for selected Asian Markets 2017-2027

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Cholera for Selected Asian Markets Cholera is a bacterial disease caused by infection from Vibrio cholerae species (O1, O139), usually spread through contaminated water. Cholera causes severe diarrhoea and dehydration. Left untreated, cholera can be fatal in a matter of hours, even in previously healthy people. This report provides the current incidence population ...

    January 2017    |    $2300    |    View Details >>

  • Cryptosporidium Forecast for selected Asian Markets 2017-2027

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Cryptosporidium in Selected Asian Markets Cryptosporidium is a microscopic parasite (Apicomplexan oocyst-forming protozoan) that causes the diarrhoeal disease cryptosporidiosis. Both the parasite and the disease are also known as "Crypto." There are ~20 different species of Cryptosporidium; however the main two species that infect humans are C. hominis and C. parvum (also ...

    January 2017    |    $2300    |    View Details >>

  • Norovirus Forecast for selected Asian Markets 2017-2027

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Norovirus in Selected Asian Markets Norovirus, also known as Norwalk virus or Norwalk-like viruses (NLV), are a group of non-enveloped, single-stranded RNA viruses that cause acute gastroenteritis. Noroviruses belong to the family Caliciviridae which includes sapoviruses, which also cause acute gastroenteritis. Currently, there are six recognized norovirus genogroups, three of which (GI, GII, ...

    January 2017    |    $2300    |    View Details >>

  • Epiomic Epidemiology Series: Adult Obstructive Sleep Apnoea Forecast in 8 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Adult Obstructive Sleep Apnoea in 8 Major Markets Adult obstructive sleep apnoea, otherwise known as Obstructive Sleep Apnea-Hypopnea (OSAH), is a sleep disorder that involves cessation or significant decrease in airflow in the presence of breathing effort. It is the most common type of sleep-disordered breathing (SDB) and is characterized by recurrent ...

    December 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Acne Vulgaris Forecast in 15 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Acne Vulgaris in 15 Major Markets Acne, or Acne Vulgaris (AV), is a chronic inflammatory disease of the pilosebaceous unit. Although acne can develop at any age, it most commonly affects adolescents and is triggered by the overproduction of sebum in the sebaceous glands. Acne vulgaris is characterised by presence of comedones, ...

    December 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Polycythemia Vera Forecast in 27 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Polycythemia Vera in 27 Major Markets Polycythemia Vera (PV), also known as erythraemia, erythrocytosis, erythrocytosis megalosplenica, Osler disease, primary polycythemia, polycythemia rubra vera or Vaquez disease, is the over production of red blood cells as a result of acquired mutations in an early blood-forming cell. Since these early blood-forming cells have the ...

    December 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series Fragile X Syndrome Forecast in 11 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Fragile X Syndrome in 11 Major Markets Fragile X syndrome (FXS) is an X-linked dominant genetic disorder. It is caused by a defect in the fragile-X mental retardation 1 gene (FRM1); this defect prevents the FRM1 gene from expressing FMRP. The FMRP protein, most commonly found in the brain, is essential for ...

    November 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series Hypertension Forecast in 12 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Hypertension in 12 Major Markets Hypertension (high blood pressure) is a common condition in which the force of the blood against the artery walls is high enough that it may eventually cause serious health problems. These health problems include heart attack, stroke, chronic kidney disease and heart failure. This report provides the ...

    November 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Rheumatoid Arthritis Forecast in 17 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Rheumatoid Arthritis in 17 Major Markets Rheumatoid arthritis (RA) is classified as an autoimmune disease and occurs when the immune system attacks the synovium (membranes surrounding joints). The inflammation resulting from the attack causes thickening of the synovium, which eventually destroys the cartilage and bone within the joint. The tendons and ligaments ...

    October 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Lower Back Pain and Sciatica Forecast in 9 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Lower Back Pain and Sciatica in 9 Major Markets Low back pain (LBP) is defined as experiencing musculoskeletal pain, muscle tension, or stiffness localized below the bottom edge of the rib cage and above the gluteal sulcus, with or without sciatica, and is defined as chronic when it persists for 12 weeks ...

    October 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Traumatic Brain Injury Forecast in 21 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Traumatic Brain Injury in 21 Major Markets Traumatic brain injury (TBI) or acquired brain injury is a non-specific term describing blunt, penetrating or blast injuries to the brain. Injury can be focal or diffuse. Focal TBI tends to be caused by sudden contact (e.g. blow to the head) whereas diffuse TBI suggests ...

    October 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Hodgkins Lymphoma Forecast in 17 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Hodgkin’s Lymphoma in 17 Major Markets Hodgkin’s Lymphoma (HL) is a cancer (also known as Hodgkin Disease, Hodgkin Lymphoma or Hodgkin’s Disease) of the lymphatic system and is one of two common types of cancers of the lymphatic system. The inclusion of Reed Sternberg cells, a type of white blood cell called ...

    October 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Osteoarthritis Forecast in 9 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Osteoarthritis in 9 Major Markets Osteoarthritis (OA), also known as degenerative joint disease / degenerative arthritis, is an inflammation of the articular cartilage and sub-chondral bone. OA is actually a collection of diseases rather than one disease per se: can be primary (chronic degenerative disorder related to but not caused by age, ...

    October 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Cervical Cancer Forecast in 22 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Cervical Cancer in 22 Major Markets Cervical cancer (ICD-10 code C53, cervix uteri) is a type of cancer that occurs in the cells of the cervix. Cervical cancer is generally preceded by Cervical Intraepithelial Neoplasia (CIN). Nearly all cervical cancer cases (>90%) have been linked with HPV infection, with identification of 14 ...

    October 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series Haemophagocytic lymphohistiocytosis HLH Forecast in 14 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Haemophagocytic lymphohistiocytosis in 14 Major Markets Haemophagocytic lymphohistiocytosis (HLH) is an extremely rare haematological disorder. It occurs when there is an uncontrollable proliferation of hyper-activated macrophages and T-lymphocytes. The hyper-activated macrophages engulf haematopoietic cells resulting in a deregulated immune system, which in turn attacks various tissues in the body. The weakened body ...

    October 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Cachexia Forecast in 8 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Cachexia in 8 Major Markets According to the most recent consensus statement (Muscaritoli et al 2010), cachexia can be defined as weight loss exceeding 5% within the previous 3-12 months in patients with long term chronic conditions OR BMI < 20 kg/m², combined with symptoms characteristic for cachexia, loss of skeletal muscle ...

    September 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Asthma Forecast in 8 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Asthma in 8 Major Markets Asthma is a chronic disease involving airway inflammation, reversible airflow obstruction, and bronchial hyper-responsiveness. The condition is usually triggered by environmental factors of which the symptoms include: difficulty breathing, coughing, wheezing and in some cases a life-threatening asthma attack. Although the condition is not currently curable, the ...

    September 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Sarcopenia Forecast in 13 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Sarcopenia in 13 Major Markets Sarcopenia is defined as the progressive and generalised loss of skeletal muscle as a natural result of the ageing process. Loss of muscle mass tends to start any time after the age of 30, but the accompanying loss of strength increases exponentially with age. Sarcopenia is characterised ...

    September 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Alpha-1 Anti-Trypsin Deficiency Forecast in 9 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Alpha-1 Anti-Trypsin in 9 Major Markets Alpha-1 Anti-Trypsin (AAT) is an enzyme belonging to the serpin super family, and is also referred to as alpha-1 proteinase inhibitor (A1PI) because it inhibits a wide variety of proteases. AAT protects tissues from enzymes of inflammatory cells, especially neutrophil elastase protein. In its absence (such ...

    September 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Non-Melanoma Skin Cancer Forecast in 8 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Non-Melanoma Skin Cancer in 8 Major Markets Non-melanoma skin cancer (NMSC) is cancer of the skin not arising from melanocytes. It is one of the most frequently occurring cancers, although it tends not to be reported via registries as prognosis for patients is good in most cases. There are two main types ...

    September 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: HIV Forecast in 8 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on HIV in 8 Major Markets The human immunodeficiency virus (HIV) is a lentivirus that causes chronic viral infection. HIV damages the immune system and prevents the body from fighting off the organisms that cause infection and disease. Without early diagnosis and treatment of HIV, the body can go on to develop AIDS. ...

    September 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Prostate Cancer Forecast in 18 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Prostate Cancer in 18 Major Markets Prostate cancer is one of the most common cancers in men. The prostate, found only in men, is the size and shape of a walnut and grows bigger with age. It sits underneath the bladder and in front of the rectum. It surrounds part of the ...

    September 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Hip Fractures and Replacements - Forecast for the USA 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Hip Fractures & Replacements for the USA Hip fractures are defined as a break in the upper quarter of the femur. The extent and exact location of the damage determines the resulting treatment. Hip fractures most commonly occur in those with low bone mineral density (BMD). While hip fractures can occur at any ...

    August 2016    |    $3200    |    View Details >>

  • Epiomic Epidemiology Series: Dry Eye Syndrome Forecast in 14 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Dry Eye Syndrome in 14 Major Markets Dry Eye Syndrome (DES), also known as Keratoconjunctivitis sicca, is a multi-factorial disorder of the tear film which occurs due to a tear deficiency or excessive tear evaporation. Dry Eye Syndrome is categorized by inflammation of the ocular surface and the lachrymal glands. Patients will ...

    August 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Autoimmune Haemolytic Anemia Forecast in 8 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Autoimmune Haemolytic Anaemia (AIHA) in 8 Major Markets Autoimmune haemolytic anaemia (AIHA) is an immune disorder caused by auto-antibodies against unmodified autologous red blood cells and can range in presentation from a mild illness to a rapidly fatal severe condition. This report provides the current incident population for AIHA across 8 Major ...

    July 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Malignant Melanoma Forecast in 20 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Malignant Melanoma in 20 Major Markets Cutaneous Malignant Melanoma is a form of cancer of the skin arising from melanocytes on the external surface of the skin. It can occur anywhere on the body and is more aggressive than the other two forms of skin cancer (basal cell and squamous cell non-melanoma ...

    June 2016    |    $5850    |    View Details >>

  • Market Report for PET Imaging in the USA

    Market Report for PET Imaging in the USA This report provides information on the current Positron Emission Tomography (PET) scanner and cyclotron install base in the USA market. Along with the current known number of PET scanners and cyclotrons in the USA, the report also contains a detailed breakdown of this equipment by year of installation, manufacturer, model, specific location and ...

    May 2016    |    $6400    |    View Details >>

  • Market Report for PET Imaging in Top 5 EU Markets

    Market Report for PET Imaging in the Top Five European Markets (T5 EU) This report provides information on the current Positron Emission Tomography (PET) scanner and cyclotron install base in the Top Five European Markets (T5 EU), which includes France, Germany, Italy, Spain and the United Kingdom. Along with the current known number of PET scanners and cyclotrons in T5 EU, ...

    May 2016    |    $16200    |    View Details >>

  • Market Report for PET Imaging in Japan

    Market Report for PET Imaging in Japan This report provides information on the current Positron Emission Tomography (PET) scanner and cyclotron install base in Japan. Along with the current known number of PET scanners and cyclotrons in Japan, the report also contains a detailed breakdown of this equipment by year of installation, manufacturer, model, specific location and current utilization. The future ...

    May 2016    |    $8780    |    View Details >>

  • Epiomic Epidemiology Series Uterine Cancer Forecast in 25 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Uterine Cancer in 25 Major Markets Uterine Cancer, or Corpus Uteri, is defined as any invasive neoplasm of the uterine corpus. It most commonly occurs in the endometrium (~75% of all uterine cancers), the mucous membrane that lines the inner surface of the uterus. It is not currently known what causes uterine ...

    May 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series Growth Hormone Deficiency Forecast in 9 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Growth Hormone Deficiency (GHD) in 9 Major Markets Growth Hormone Deficiency (GHD) results from the destruction of normal pituitary and hypothalamic tissue and is characterized by the inadequate secretion of growth hormone (GH), from the anterior pituitary gland. GHD can occur at any point during an individual’s life, but is primarily defined ...

    May 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series Bladder Cancer Forecast in 18 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Bladder Cancer in 18 Major Markets Bladder Cancer is cancer arising in the urinary bladder, generally from urothelial cells. It is the fourth most common cancer in males and the ninth most common in females. While Bladder Cancer is associated with significant morbidity and mortality, prognosis tends to be good with 80-100% ...

    May 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series Traumatic Spinal Cord Injury Forecast in 15 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Traumatic Spinal Cord Injury (TSCI) in 15 Major Markets Spinal cord injury is defined as damage to any part of the spinal cord or nerves at the end of the spinal canal, often resulting in permanent changes in strength, sensation and other body functions below the site of the injury. Traumatic spinal ...

    May 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series Dysmenorrhea Forecast in 21 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Dysmenorrhea in 21 Major Markets Dysmenorrhoea is a common menstrual complaint, also known as painful menstruation. It is defined as severe, painful cramping in the lower abdomen beginning shortly before or at the onset of menses. Dysmenorrhoea is often accompanied by other symptoms such as sweating, headaches, nausea, vomiting and diarrhoea. Dysmenorrhea ...

    May 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series Brain and CNS Cancer Forecast in 19 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Brain & CNS Cancer in 19 Major Markets Primary brain and central nervous system (CNS) tumours (ICD-10 codes C70-C72) are a group of primary tumours arising in the brain, meninges or central nervous system. As such, this is a cluster of conditions rather than one disease per se. There are considered to ...

    May 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Brain & CNS Cancer Forecast in 19 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Brain & CNS Cancer in 19 Major Markets Primary brain and central nervous system (CNS) tumours (ICD-10 codes C70-C72) are a group of primary tumours arising in the brain, meninges or central nervous system. As such, this is a cluster of conditions rather than one disease per se. There are considered to ...

    May 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Glaucoma Forecast in 10 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Glaucoma in 10 Major Markets Glaucoma is a term describing a group of eye disorders that result in optic nerve damage. Glaucoma is divided into two main types: open-angle or closed-angle glaucoma. The condition develops when excess aqueous humour is inadequately drained, causing pressure to build. This may damage the optic nerves ...

    April 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Tay-Sachs Disease Forecast in 9 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Tay Sachs Disease (TSD) in 9 Major Markets Hexosaminidase A deficiency (HEX A deficiency) results in a group of neurodegenerative disorders caused by the dysfunctional activity of the specific glycosphingolipid GM2 ganglioside. The disease occurs when cell membrane components known as gangliosides, accumulate to toxic levels, particularly in neurons in the brain ...

    April 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Primary Immunodeficiency Disease Forecast in 21 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Primary Immunodeficiency Diseases (PID) in 21 Major Markets Primary immunodeficiency diseases (PID) are a group of inherited genetic disorders of the genes governing the immune system. PIDs are a group of more than 200 rare, chronic disorders in which part of the bodys immune system is missing or functions improperly. Some types ...

    April 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Essential Thrombocythemia Forecast in 9 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Essential Thrombocythemia (ET) in 9 Major Markets Essential Thrombocythemia (ET) or Primary Thrombocythemia, is a rare, chronic myeloproliferative disorder that involves the over production of blood platelets by the bone marrow. ET is characterized by a persisting elevated platelet count >450,000/µL, with megakaryocytic hyperplasia, and patients will likely also suffer from splenomegaly ...

    April 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Chronic Kidney Disease Forecast in 19 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Chronic Kidney Disease (CKD) in 19 Major Markets Chronic kidney disease (CKD), also known as chronic renal disease, is characterised by progressive loss of kidney function over time. CKD is defined as persisting kidney damage or a glomerular filtration rate (GFR) of <60 mL/min/1.73 m2 for ? 3 months. This damage refers ...

    April 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Age-Related Macular Degeneration Forecast in 7 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Age-related Macular Degeneration (AMD) Disease in 7 Major Markets Age-related macular degeneration (AMD or ARMD) or Age-related Maculopathy (ARM) is a condition that involves the degeneration and damage to the central area of the retina – the macula. It is currently a common cause of visual impairment in Western Europe. AMD is ...

    April 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Primary Myleofibrosis Forecast in 8 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Primary Myelofibrosis (PMF) in 8 Major Markets Primary Myelofibrosis (PMF), also known as myelofibrosis, myeloid metaplasia or chronic idiopathic myelofibrosis, is part of the collection of diseases known as myeloproliferative neoplasms (MPNs). PMF is a chronic blood cancer that affects the haematopoietic system, causing progressive fibrosis of the bone marrow and impairs ...

    April 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series Glaucoma Forecast in 10 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Glaucoma in 10 Major Markets Glaucoma is a term describing a group of eye disorders that result in optic nerve damage. Glaucoma is divided into two main types: open-angle or closed-angle glaucoma. The condition develops when excess aqueous humour is inadequately drained, causing pressure to build. This may damage the optic ...

    April 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series Tay-Sachs Disease Forecast in 9 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Tay Sachs Disease (TSD) in 9 Major Markets Hexosaminidase A deficiency (HEX A deficiency) results in a group of neurodegenerative disorders caused by the dysfunctional activity of the specific glycosphingolipid GM2 ganglioside. The disease occurs when cell membrane components known as gangliosides, accumulate to toxic levels, particularly in neurons in the brain ...

    April 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series Primary Immunodeficiency Disease Forecast in 21 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Primary Immunodeficiency Diseases (PID) in 21 Major Markets Primary immunodeficiency diseases (PID) are a group of inherited genetic disorders of the genes governing the immune system. PIDs are a group of more than 200 rare, chronic disorders in which part of the body’s immune system is missing or functions improperly. Some types ...

    April 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series Essential Thrombocythemia Forecast in 9 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Essential Thrombocythemia (ET) in 9 Major Markets Essential Thrombocythemia (ET) or Primary Thrombocythemia, is a rare, chronic myeloproliferative disorder that involves the over production of blood platelets by the bone marrow. ET is characterized by a persisting elevated platelet count >450,000/µL, with megakaryocytic hyperplasia, and patients will likely also suffer from splenomegaly ...

    April 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series Chronic Kidney Disease Forecast in 19 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Chronic Kidney Disease (CKD) in 19 Major Markets Chronic kidney disease (CKD), also known as chronic renal disease, is characterised by progressive loss of kidney function over time. CKD is defined as persisting kidney damage or a glomerular filtration rate (GFR) of <60 mL/min/1.73 m2 for ? 3 months. This damage refers ...

    April 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series Age-Related Macular Degeneration Forecast in 7 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Age-related Macular Degeneration (AMD) Disease in 7 Major Markets Age-related macular degeneration (AMD or ARMD) or Age-related Maculopathy (ARM) is a condition that involves the degeneration and damage to the central area of the retina – the macula. It is currently a common cause of visual impairment in Western Europe. AMD is ...

    April 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series Primary Myleofibrosis Forecast in 8 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Primary Myelofibrosis (PMF) in 8 Major Markets Primary Myelofibrosis (PMF), also known as myelofibrosis, myeloid metaplasia or chronic idiopathic myelofibrosis, is part of the collection of diseases known as myeloproliferative neoplasms (MPNs). PMF is a chronic blood cancer that affects the haematopoietic system, causing progressive fibrosis of the bone marrow and impairs ...

    April 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series Multiple Myeloma Forecast in 18 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Multiple Myeloma in 18 Major Markets Multiple Myeloma is a cancer of plasma cells and is characterized by the production of abnormal immunoglobulins (Ig) or antibodies, as well as an accumulation of malignant plasma cells in the bone marrow. In some cases it can be asymptomatic, known as “smouldering” Multiple Myeloma. Although ...

    April 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Familial Dyslipidaemia Forecast in 8 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Dyslipidaemia (Familial Type) in 8 Major Markets Dyslipidaemia is defined as individuals with elevated triglycerides, low density lipoprotein or total cholesterol, or with lowered levels of high density lipoprotein. Many patients meet the requirements of Dyslipidaemia on more than one factor. Dyslipidaemia can be divided into two forms: familial (primary) or acquired ...

    March 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Prader-Willi Syndrome Forecast in 9 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Prader-Willi Syndrome in 9 Major Markets Prader-Willi syndrome (PWS) is a genetic disease caused by the loss of function of several genes in a particular region of chromosome 15, affecting many parts of the body. These genes provide instructions for making molecules called small nucleolar RNAs (snRNAs) which have a variety of ...

    March 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Benign Prostatic Hypertrophy Forecast in 17 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Benign Prostatic Hypertrophy (BPH) Disease in 17 Major Markets Benign Prostatic Hypertrophy (BPH) is a noncancerous (benign) enlargement of the prostate gland that can make urination difficult. The precise cause is not known but most likely involves changes caused by hormones, including testosterone and especially androgen dihydrotestosterone. The prostate enlarges over time ...

    March 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Juvenile Idiopathic Arthritis Forecast in 8 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Juvenile Idiopathic Arthritis (JIA) in 8 Major Markets Juvenile Idiopathic Arthritis (JIA) is an auto-immune disorder defined as inflammation of the joints. For diagnosis, the inflammation in one or more of the joints must be present for at least six weeks, affecting children under the age of 16. There are 6 main ...

    March 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Addison-s Disease Forecast in 10 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Addisons Disease in 10 Major Markets Addison-s disease (AD) is a chronic and rare endocrinal disorder, caused by destruction of the adrenal cortex which leads to the reduced production of glucocorticoids, mineralocorticoids and adrenal androgens. Chronic adrenal insufficiency and hypersecretion of ACTH is representative of the basic clinical signs and symptoms. AD ...

    March 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Transient Ischaemic Attack Forecast in 8 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Transient Ischaemic Attack (TIA) in 8 Major Markets Transient ischaemic attack (TIA), also known as a mini or minor stroke, is an acute episode that results in a temporary loss of neurologic function. Similar to strokes, they are caused by the disruption of cerebral blood flow which can happen as a result ...

    March 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Behcet-s Disease Forecast in 12 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Behcets Disease in 12 Major Markets Behçet-s disease (BD), also known as Silk Road Disease or Adamantiades-Behçets Disease, is a rare disease classified amongst a group of disorders termed “vasculitides”. The pathophysiology is thought to be autoimmune, linked to the HLA-B5/51 antigen. As a multisystem disease, clinical manifestations can involve nearly all ...

    March 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Amyotrophic Lateral Sclerosis Forecast in 9 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Amyotrophic Lateral Sclerosis in 9 Major Markets Amyotrophic lateral sclerosis (ALS), also called Lou Gehrig-s disease or motor neuron disease, is a is a rapidly progressive, fatal neurological disease in which upper and lower motor neurons degrade and eventually die. As motor function decreases, muscles weaken and waste; eventually the brain is ...

    March 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Addison's Disease Forecast in 10 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Addison’s Disease in 10 Major Markets Addison's disease (AD) is a chronic and rare endocrinal disorder, caused by destruction of the adrenal cortex which leads to the reduced production of glucocorticoids, mineralocorticoids and adrenal androgens. Chronic adrenal insufficiency and hypersecretion of ACTH is representative of the basic clinical signs and symptoms. AD ...

    March 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Behcet's Disease Forecast in 12 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Behcet’s Disease in 12 Major Markets Behçet's disease (BD), also known as Silk Road Disease or Adamantiades-Behçet’s Disease, is a rare disease classified amongst a group of disorders termed “vasculitides”. The pathophysiology is thought to be autoimmune, linked to the HLA-B5/51 antigen. As a multisystem disease, clinical manifestations can involve nearly all ...

    March 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series Familial Dyslipidaemia Forecast in 8 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Dyslipidaemia (Familial Type) in 8 Major Markets Dyslipidaemia is defined as individuals with elevated triglycerides, low density lipoprotein or total cholesterol, or with lowered levels of high density lipoprotein. Many patients meet the requirements of Dyslipidaemia on more than one factor. Dyslipidaemia can be divided into two forms: familial (primary) or acquired ...

    March 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series Prader-Willi Syndrome Forecast in 9 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Prader-Willi Syndrome in 9 Major Markets Prader-Willi syndrome (PWS) is a genetic disease caused by the loss of function of several genes in a particular region of chromosome 15, affecting many parts of the body. These genes provide instructions for making molecules called small nucleolar RNAs (snRNAs) which have a variety of ...

    March 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series Benign Prostatic Hypertrophy Forecast in 17 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Benign Prostatic Hypertrophy (BPH) Disease in 17 Major Markets Benign Prostatic Hypertrophy (BPH) is a noncancerous (benign) enlargement of the prostate gland that can make urination difficult. The precise cause is not known but most likely involves changes caused by hormones, including testosterone and especially androgen dihydrotestosterone. The prostate enlarges over time ...

    March 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series Juvenile Idiopathic Arthritis Forecast in 8 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Juvenile Idiopathic Arthritis (JIA) in 8 Major Markets Juvenile Idiopathic Arthritis (JIA) is an auto-immune disorder defined as inflammation of the joints. For diagnosis, the inflammation in one or more of the joints must be present for at least six weeks, affecting children under the age of 16. There are 6 main ...

    March 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series Addisons Disease Forecast in 10 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Addison’s Disease in 10 Major Markets Addisons disease (AD) is a chronic and rare endocrinal disorder, caused by destruction of the adrenal cortex which leads to the reduced production of glucocorticoids, mineralocorticoids and adrenal androgens. Chronic adrenal insufficiency and hypersecretion of ACTH is representative of the basic clinical signs and symptoms. AD ...

    March 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series Transient Ischaemic Attack Forecast in 8 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Transient Ischaemic Attack (TIA) in 8 Major Markets Transient ischaemic attack (TIA), also known as a mini or minor stroke, is an acute episode that results in a temporary loss of neurologic function. Similar to strokes, they are caused by the disruption of cerebral blood flow which can happen as a result ...

    March 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series Behcets Disease Forecast in 12 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Behcet’s Disease in 12 Major Markets Behçets disease (BD), also known as Silk Road Disease or Adamantiades-Behçet’s Disease, is a rare disease classified amongst a group of disorders termed “vasculitides”. The pathophysiology is thought to be autoimmune, linked to the HLA-B5/51 antigen. As a multisystem disease, clinical manifestations can involve nearly all ...

    March 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series Amyotrophic Lateral Sclerosis Forecast in 9 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Amyotrophic Lateral Sclerosis in 9 Major Markets Amyotrophic lateral sclerosis (ALS), also called Lou Gehrigs disease or motor neuron disease, is a is a rapidly progressive, fatal neurological disease in which upper and lower motor neurons degrade and eventually die. As motor function decreases, muscles weaken and waste; eventually the brain is ...

    March 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Restless Leg Syndrome Forecast in 13 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Restless Legs Syndrome in 13 Major Markets
    Restless Legs Syndrome (RLS), also known as Willis-Ekbom Disorder, is a sensimotor sleep disorder. Clinically, RLS is characterized by disagreeable leg sensations occurring most often at sleep onset that provoke an irresistible urge to move legs. Patients with RLS typically complain of itching, creeping and ...

    February 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Pancreatic Cancer Forecast in 17 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Forecast Report on Pancreatic Cancer in 17 Major Markets Pancreatic cancer is one of the most deadly cancers in the world. Pancreatic cancer is a result of malignant cells forming in the tissue of the pancreas, and typically spreads rapidly with detection usually in the later stages of the disease. The prognosis of pancreatic cancer, especially ...

    February 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Symptomatic Vitreomacular Adhesion Forecast in 9 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Symptomatic Vitreomacular Adhesion in 9 Major Markets Symptomatic Vitreomacular adhesion (VMA) is a rare macular condition caused by an incomplete posterior vitreous detachment from the retina, located at the back of the eye, with remaining vitreomacular attachment and unperturbed foveal morphologic features. It is almost always the result of normal vitreous aging, ...

    February 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Ulcerative Colitis Forecast in 8 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Ulcerative Colitis in 8 Major Markets Ulcerative Colitis (UC) is an inflammatory bowel disease (IBD) causing chronic inflammation in the colon, and is treated as an autoimmune disease. While sharing some features with Crohn-s disease, UC is an intermittent disease with periods of symptoms interspersed with asymptomatic periods (generally induced by response ...

    February 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Peripheral Arterial Disease Forecast in 20 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Peripheral Arterial Disease (PAD) in 20 Major Markets Peripheral Arterial disease (PAD) is an occlusion of the peripheral arteries and is widely viewed as a measure of an individual-s global systemic atherosclerotic burden. Typically, it is defined as an ankle-brachial pressure index (APBI) ratio of <0.9. PAD can also be known as ...

    February 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Systemic Lupus Erythematosus Forecast in 8 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Systemic Lupus Erythematosus in 8 Major Markets Systemic Lupus Erythematosus (SLE) is an autoimmune disease, characterised by an autoantibody response to nuclear and cytoplasmic antigens. It is a systemic disease, with a large spectrum of signs and symptoms. It is a chronic condition that follows a relapsing and remitting course of its ...

    February 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series: Stomach Cancer Forecast in 17 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Stomach Cancer in 17 Major Markets Stomach cancer is a broad term encompassing tumours arising in the stomach and includes gastric carcinoma which is a malignant epithelial-origin tumour commonly developing after prolonged periods of gastritis. Stomach cancers tend to develop slowly over many years spreading in different ways. Long-term infection of the ...

    February 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series Restless Leg Syndrome Forecast in 13 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Restless Legs Syndrome in 13 Major Markets Restless Legs Syndrome (RLS), also known as Willis-Ekbom Disorder, is a sensimotor sleep disorder. Clinically, RLS is characterized by disagreeable leg sensations occurring most often at sleep onset that provoke an irresistible urge to move legs. Patients with RLS typically complain of itching, creeping and ...

    February 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series Pancreatic Cancer Forecast in 17 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Forecast Report on Pancreatic Cancer in 17 Major Markets Pancreatic cancer is one of the most deadly cancers in the world. Pancreatic cancer is a result of malignant cells forming in the tissue of the pancreas, and typically spreads rapidly with detection usually in the later stages of the disease. The prognosis of pancreatic cancer, especially ...

    February 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series Symptomatic Vitreomacular Adhesion Forecast in 9 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Symptomatic Vitreomacular Adhesion in 9 Major Markets Symptomatic Vitreomacular adhesion (VMA) is a rare macular condition caused by an incomplete posterior vitreous detachment from the retina, located at the back of the eye, with remaining vitreomacular attachment and unperturbed foveal morphologic features. It is almost always the result of normal vitreous aging, ...

    February 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series Ulcerative Colitis Forecast in 8 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Ulcerative Colitis in 8 Major Markets Ulcerative Colitis (UC) is an inflammatory bowel disease (IBD) causing chronic inflammation in the colon, and is treated as an autoimmune disease. While sharing some features with Crohns disease, UC is an intermittent disease with periods of symptoms interspersed with asymptomatic periods (generally induced by response ...

    February 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series Peripheral Arterial Disease Forecast in 20 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Peripheral Arterial Disease (PAD) in 20 Major Markets Peripheral Arterial disease (PAD) is an occlusion of the peripheral arteries and is widely viewed as a measure of an individuals global systemic atherosclerotic burden. Typically, it is defined as an ankle-brachial pressure index (APBI) ratio of <0.9. PAD can also be known as ...

    February 2016    |    $5850    |    View Details >>

  • Epiomic Epidemiology Series Systemic Lupus Erythematosus Forecast in 8 Major Markets 2016-2026

    Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Systemic Lupus Erythematosus in 8 Major Markets Systemic Lupus Erythematosus (SLE) is an autoimmune disease, characterised by an autoantibody response to nuclear and cytoplasmic antigens. It is a systemic disease, with a large spectrum of signs and symptoms. It is a chronic condition that follows a relapsing and remitting course of its ...

    February 2016    |    $5850    |    View Details >>

2017 © Copyright Big Market Research